Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roblee Allen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Pulmonary Medicine|March 17, 2004
Bronchiolitis obliterans: an updateAndrew Chan, Roblee Allen
The American Journal of Medicine|May 8, 2016
A Diagnosis at Hand: Pulmonary Arterial HypertensionKavita Khaira, Roblee Allen, Ezra A Amsterdam
Treatments in Respiratory Medicine|June 4, 2004
Epoprostenol in pregnant patients with secondary pulmonary hypertension: two case reports and a review of the literatureMark Avdalovic, Christian Sandrock, Andrea Hoso, et al.
Photodermatology, Photoimmunology & Photomedicine|March 9, 2005
Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfacesAndrew L Chan, Maya Juarez, Roblee Allen, et al.
Journal of Cardiovascular Pharmacology|January 19, 2013
Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertensionR James White, Fernando Torres, Roblee Allen, et al.
Plos One|April 22, 2014
Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertensionJ K Mansoor, Edward S Schelegle, Cristina E Davis, et al.
Circulation|January 12, 2013
Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trialZhi-Cheng Jing, Keyur Parikh, Tomas Pulido, et al.
Pulmonary Circulation|July 11, 2019
EXPRESS: Long term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokineticsR James White, Keyur Parikh, Roblee Allen, et al.
The New England Journal of Medicine|January 13, 2021
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung DiseaseAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Pulmonary Medicine|March 17, 2004
Bronchiolitis obliterans: an updateAndrew Chan, Roblee Allen
The American Journal of Medicine|May 8, 2016
A Diagnosis at Hand: Pulmonary Arterial HypertensionKavita Khaira, Roblee Allen, Ezra A Amsterdam
Treatments in Respiratory Medicine|June 4, 2004
Epoprostenol in pregnant patients with secondary pulmonary hypertension: two case reports and a review of the literatureMark Avdalovic, Christian Sandrock, Andrea Hoso, et al.
Photodermatology, Photoimmunology & Photomedicine|March 9, 2005
Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfacesAndrew L Chan, Maya Juarez, Roblee Allen, et al.
Journal of Cardiovascular Pharmacology|January 19, 2013
Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertensionR James White, Fernando Torres, Roblee Allen, et al.
Plos One|April 22, 2014
Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertensionJ K Mansoor, Edward S Schelegle, Cristina E Davis, et al.
Circulation|January 12, 2013
Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trialZhi-Cheng Jing, Keyur Parikh, Tomas Pulido, et al.
Pulmonary Circulation|July 11, 2019
EXPRESS: Long term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokineticsR James White, Keyur Parikh, Roblee Allen, et al.
The New England Journal of Medicine|January 13, 2021
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung DiseaseAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
Pageof 1